MyShare
Key factors
| sym | OBLN |
| exch | US |
| MCap | 30.56M |
| Beta | -1.24 |
| EPS | -13.2 |
| Div date | 0000-00-00 |
Yesterday
| sym | OBLN |
| exch | US |
| close | 6.3 |
| 50 Day MA | 9.140 |
| 200 Day MA | 9.083 |
| Target Price | 6.15 |
| Market Cap Mln | 30.56 |
Share statistics
| Shares Outstanding | 10.02M |
| Shares Float | 7771.36K |
| Percent Institutions | 31.7 |
| PercentInsiders | 3.229 |
| SharesShort | 684.26K |
| Short Ratio | 0.08 |
| Shares Short Prior Month | 768.99K |
| Short Percent | 8.799 |
Income
| Revenue TTM | 808.0K |
| Revenue Per Share TTM | 0.099 |
| Quarterly Revenue Growth YOY | -92.1 |
| Gross Profit TTM | 531.0K |
| EBITDA | -28.1M |
| Diluted Eps TTM | -1.37 |
earning
| Operating Margin TTM | -13.0 |
| Earnings Share | -13.2 |
Dividend
| Dividend Date | 2019-07-25 |
| Last Split Date | 2021-06-16 |
| Last Split Factor | 1:3 |
business
| Enterprise Value Ebitda | 0.118 |
| Enterprise Value Revenue | 28.36 |
| Book Value /share | 1.008 |
| Price Book MRQ | 3.026 |
| Price Sales TTM | 30.83 |
| ReturnOnAssetsTTM | -0.36 |
| ReturnOnEquityTTM | -1.06 |
Sector
| Gic Group | Health Care Equipment & Services |
| Gic Industry | Health Care Equipment & Supplies |
| Gic Sector | Health Care |
| Gic Sub Industry | Health Care Equipment |
| Industry | Medical Devices |
| Sector | Healthcare |
Codes
| ISIN | US67424L2097 |
| CIK | 1427570 |
| Code | OBLN |
| CUSIP | 67424L209 |
| Employer Id Number | 26-1828101 |
| CountryISO | US |
| Currency Code | USD |
| Currency Name | US Dollar |
| Exchange | NASDAQ |
| Currency Symbol | $ |
fund
| Type | Common Stock |
| UpdatedAt | 2021-07-25 |
| is Delisted | 1 |
| Delisted Date | 2021-06-18 |
| Home Category | Domestic |
info
| Fiscal Year End | December |
| Full Time Employees | 2.0 |
| IPODate | 2016-10-06 |
| International Domestic | Domestic |
| MostRecent Quarter | 2021-03-31 |
Contact
| Name | Obalon Therapeutics Inc |
| Address | 5421 Avenida Encinas, Carlsbad, CA, United States, 92008-4410 |
| Country Name | USA |
| Phone | 760 607 5164 |
| Web URL | www.obalon.com |
| Logo URL | /img/logos/US/OBLN.png |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.